Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)
Clinical trial NCT01156415 · TERMINATED
Trial details
- NCT number
- NCT01156415
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2011-10-01
- Enrollment
- 837
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.